Chan Mm Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chan Mm Xiong has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chen-Yi Mm Li
Department of Respiratory, No. 3 Affiliated Hospital of Chengdu University of TCM (West District), Chengdu Pidu District Hospital of TCM, Chengdu, Sichuan, China
1 shared publication - Fanrong Liang
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
1 shared publication - Fuyu Peng
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Chengdu 610075, China
1 shared publication - Guang Chen
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Chengdu 610075, China
1 shared publication - Hua Mb Wei
Department of Respiratory, No. 3 Affiliated Hospital of Chengdu University of TCM (West District), Chengdu Pidu District Hospital of TCM, Chengdu, Sichuan, China
1 shared publication - Juan-Juan Fu
Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3509
An Integrated Electronic Patient-Reported Outcome-Guided COPD Management Strategy Incorporating Adjunctive Acupuncture: Study Protocol for a Randomized Controlled Trial
Background/Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by persistent symptoms and fluctuating disease status. Effective COPD management requires not only alleviating symptom burden but also maintaining disease stability. An integrated management strategy added to usual care, combining adjunctive acupuncture for symptom control with electronic patient-reported outcome (ePRO)-guided symptom monitoring and timely clinical responses, may provide a novel approach to optimize COPD care. This trial will evaluate whether this management strategy can improve long-term COPD outcomes compared with usual care alone. Methods: This is an open-label, randomized controlled trial with blinded outcome assessments. A total of 172 patients with stable COPD will be randomized 1:1 to usual care or intervention group. The intervention consists of an initial symptom-control phase followed by an ePRO-guided monitoring and response phase with predefined clinical management adjustments. We will follow up participants for 12 months and collect data every 2 months to assess hospitalization, exacerbations, mortality, health status and safety. All analyses will adhere to the intention-to-treat principle. The primary outcome (i.e., time to first COPD-related hospitalization) will be analyzed using a cause-specific Cox proportional hazards model, with death before hospitalization treated as a competing event. The cumulative incidence of COPD-related hospitalization will be estimated using the Aalen–Johansen estimator. Conclusions: This study will evaluate, compared with usual care alone, whether an integrated ePRO-guided COPD management strategy incorporating adjunctive acupuncture could provide additional benefits. As this is the first trial of this integrated intervention, the findings should be considered preliminary and cannot determine the separate effects of the individual components. This study may provide a patient-centered management model for COPD and inform future exploration of integrative care.
- 19 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3509
Open AccessAn Integrated Electronic Patient-Reported Outcome-Guided COPD Management Strategy Incorporating Adjunctive Acupuncture: Study Protocol for a Randomized Controlled Trial
Background/Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by persistent symptoms and fluctuating disease status. Effective COPD management requires not only alleviating symptom burden but also maintaining disease stability. An integrated management strategy added to usual care, combining adjunctive acupuncture for symptom control with electronic patient-reported outcome (ePRO)-guided symptom monitoring and timely clinical responses, may provide a novel approach to optimize COPD care. This trial will evaluate whether this management strategy can improve long-term COPD outcomes compared with usual care alone. Methods: This is an open-label, randomized controlled trial with blinded outcome assessments. A total of 172 patients with stable COPD will be randomized 1:1 to usual care or intervention group. The intervention consists of an initial symptom-control phase followed by an ePRO-guided monitoring and response phase with predefined clinical management adjustments. We will follow up participants for 12 months and collect data every 2 months to assess hospitalization, exacerbations, mortality, health status and safety. All analyses will adhere to the intention-to-treat principle. The primary outcome (i.e., time to first COPD-related hospitalization) will be analyzed using a cause-specific Cox proportional hazards model, with death before hospitalization treated as a competing event. The cumulative incidence of COPD-related hospitalization will be estimated using the Aalen–Johansen estimator. Conclusions: This study will evaluate, compared with usual care alone, whether an integrated ePRO-guided COPD management strategy incorporating adjunctive acupuncture could provide additional benefits. As this is the first trial of this integrated intervention, the findings should be considered preliminary and cannot determine the separate effects of the individual components. This study may provide a patient-centered management model for COPD and inform future exploration of integrative care.
- Open Access
- 14 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (41) , e30909
Acupuncture for dyspnea and breathing physiology in chronic respiratory diseases: A protocol of a systematic review and meta-analysis of randomized controlled trials
Background: Dyspnea is one of the most common symptoms of chronic respiratory disease (CRD) and is closely related to increased functional disability and mortality, resulting in substantial adverse outcomes on patients and imposing great social and economic burden. Although multiple clinical trials and systematic reviews have suggested that acupuncture could be effective in treating COPD and lung cancer, little is known about its effects on dyspnea relief in patients with CRD. The present study aimed to use a systematic review approach to evaluate the effectiveness and safety of acupuncture in the treatment of dyspnea in patients with CRD. Methods: We will search the following 9 databases from inception to June 30, 2022, PubMed, Web of Science, EMBASE, Cochrane Central Register of Controlled Trials, Chinese National Knowledge Infrastructure, WANFANG Database, Chinses Scientific and Technological Periodical Database, and Chinese Biomedical Database, and the Cochrane Library Database. Clinical randomized controlled trials in English or Chinese that evaluate invasive acupuncture versus control group in treatment of CRD with dyspnea will be included. The primary outcome will be dyspnea scores, breathing physiological function, and the secondary outcomes include exercise tolerance by six-minute walk distance quality of life, quality of life and adverse events. Two reviewers will independently conduct study selection, data extraction and quality assessment. The Review Manager software will be used for meta-analysis. This protocol will be carried out in accordance with the PRISMA-P guidance. Conclusion: This systematic review and meta-analysis will provide the evidence of whether acupuncture is an effective and safe intervention for CRD with dyspnea. The results will be disseminated through peer-reviewed publication.
- 14 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (41) , e30909
Open AccessAcupuncture for dyspnea and breathing physiology in chronic respiratory diseases: A protocol of a systematic review and meta-analysis of randomized controlled trials
Background: Dyspnea is one of the most common symptoms of chronic respiratory disease (CRD) and is closely related to increased functional disability and mortality, resulting in substantial adverse outcomes on patients and imposing great social and economic burden. Although multiple clinical trials and systematic reviews have suggested that acupuncture could be effective in treating COPD and lung cancer, little is known about its effects on dyspnea relief in patients with CRD. The present study aimed to use a systematic review approach to evaluate the effectiveness and safety of acupuncture in the treatment of dyspnea in patients with CRD. Methods: We will search the following 9 databases from inception to June 30, 2022, PubMed, Web of Science, EMBASE, Cochrane Central Register of Controlled Trials, Chinese National Knowledge Infrastructure, WANFANG Database, Chinses Scientific and Technological Periodical Database, and Chinese Biomedical Database, and the Cochrane Library Database. Clinical randomized controlled trials in English or Chinese that evaluate invasive acupuncture versus control group in treatment of CRD with dyspnea will be included. The primary outcome will be dyspnea scores, breathing physiological function, and the secondary outcomes include exercise tolerance by six-minute walk distance quality of life, quality of life and adverse events. Two reviewers will independently conduct study selection, data extraction and quality assessment. The Review Manager software will be used for meta-analysis. This protocol will be carried out in accordance with the PRISMA-P guidance. Conclusion: This systematic review and meta-analysis will provide the evidence of whether acupuncture is an effective and safe intervention for CRD with dyspnea. The results will be disseminated through peer-reviewed publication.